Back
ArrowMark Financial Vs. Corcept Therapeutics Industry Stock Comparison
Sell
28
BANX
ArrowMark Financial
Last Price:
$19.41
Seasonality Move:
2.21%
Buy
53
CORT
Corcept Therapeutics
Last Price:
$74.48
Seasonality Move:
6.42%
Sell
28
ArrowMark Financial (BANX)
is a Sell
Is ArrowMark Financial a Buy, Sell or Hold?
-
The current ArrowMark Financial [BANX] share price is $19.30. The Score for BANX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
BANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $74.45. The Score for CORT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BANX Stock Price Chart
What is ArrowMark Financial's stock price today?
-
The ArrowMark Financial share price today is $19.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BANX is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $74.45The current trend is moderately bullish and CORT is experiencing slight selling pressure.
BANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 23.89 | Sell |
| Chaikin Money Flow: | -35179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.56 - 21.36) | Sell |
| Bollinger Bands (100): | (20.62 - 21.22) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.52 | Buy |
| Relative Strength Index (14 RSI): | 54.19 | Buy |
| Chaikin Money Flow: | -794120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.93 - 77.53) | Buy |
| Bollinger Bands (100): | (50.62 - 69.12) | Buy |
BANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.74 | Sell |
| 20-day SMA: | 20.92 | Sell |
| 50-day SMA: | 21.04 | Sell |
| 200-day SMA: | 20.38 | Sell |
| 8-day EMA: | 20.53 | Sell |
| 20-day EMA: | 20.81 | Sell |
| 50-day EMA: | 20.93 | Sell |
| 200-day EMA: | 20.34 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.53 | Sell |
| 20-day SMA: | 64.77 | Buy |
| 50-day SMA: | 64.61 | Buy |
| 200-day SMA: | 48.89 | Buy |
| 8-day EMA: | 73.83 | Buy |
| 20-day EMA: | 51.72 | Buy |
| 50-day EMA: | 27.44 | Buy |
| 200-day EMA: | 8.02 | Buy |
ArrowMark Financial Earnings Growth & BANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
ArrowMark Financial Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||